\u003cp\u003e\u003ci\u003ePrivileged Scaffolds in Drug Discovery\u003c/i\u003e is the most complete and up-to-date work in the area. Covering a wide range of privileged structures, it is a perfect reference for scientists involved in targeted drug development.\u003c/p\u003e \u003cp\u003eThe editors recruited epserts from several prestigious Chinese institutions to cover the areas of antiviral drugs, chalcone, pyrimidine, (benz)imidazoles, natural product-derived privileged scaffolds, N-Sulfonyl carboxamides, kinase inhibitors, antitumor molecules, antineurodegenerative drugs, triazoles, oxazolidinone, indole and indoline scaffolds, tigliane diterpenoids, peptide and peptide-based drugs, quassinoids, and others including pseudonatural products, macrocycles, stable peptides and peptidomimetics. The book also explores scaffolds in drug molecules approved in recent years. \u003c/p\u003e \u003cp\u003e\u003ci\u003ePrivileged Scaffolds in Drug Discovery\u003c/i\u003e is a complete reference for researchers in drug discovery and organic synthesis, in academic and corporate settings, who are investigating privileged structures upon which to base new drugs. Researchers in medicinal chemistry and chemical biology will also find the contents of this book valuable.\u003c/p\u003e\u003cul\u003e\u003cli\u003eProvides wide coverage of privileged scaffolds in new drug discovery\u003c/li\u003e\u003cli\u003eIncludes complex and diverse natural product scaffolds\u003c/li\u003e\u003cli\u003eCovers applications to peptides and peptide-based drugs\u003c/li\u003e\u003c/ul\u003e
nl
en